77 related articles for article (PubMed ID: 25736684)
1. Bufalin is a steroid receptor coactivator inhibitor-response.
Lonard DM; Xu J; O'Malley BW
Cancer Res; 2015 Mar; 75(6):1157. PubMed ID: 25736684
[No Abstract] [Full Text] [Related]
2. Bufalin is a steroid receptor coactivator inhibitor-letter.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; García-Domínguez I; Maldonado-Navas D; López-Lázaro M
Cancer Res; 2015 Mar; 75(6):1156. PubMed ID: 25736686
[No Abstract] [Full Text] [Related]
3. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract][Full Text] [Related]
4. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
Rohira AD; Lonard DM
Biochem Pharmacol; 2017 Sep; 140():1-7. PubMed ID: 28390937
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin.
Nakano H; Matsunawa M; Yasui A; Adachi R; Kawana K; Shimomura I; Makishima M
Biochem Pharmacol; 2005 Nov; 70(10):1479-86. PubMed ID: 16183038
[TBL] [Abstract][Full Text] [Related]
6. Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells.
Amano Y; Cho Y; Matsunawa M; Komiyama K; Makishima M
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):144-51. PubMed ID: 19429444
[TBL] [Abstract][Full Text] [Related]
7. Bufalin, a bufanolide steroid from the parotoid glands of the Chinese toad, suppresses hERG K
Song T; Zhang Y; Song Q; Han X; Guan S; Zhang X; Chu X; Zhang F; Zhang J; Chu L
Fundam Clin Pharmacol; 2017 Dec; 31(6):695-700. PubMed ID: 28755515
[TBL] [Abstract][Full Text] [Related]
8. [The mechanisms of inhibitory effect of bufalin on human leukemia cells].
Xu R; Chen X; Chen L; Qian J
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):359-61. PubMed ID: 11877005
[TBL] [Abstract][Full Text] [Related]
9. Bufalin, a bufanolide steroid from the parotoid glands of the Chinese toad, inhibits L-type Ca
Song T; Chu X; Zhang X; Song Q; Zhang Y; Zhang Y; Han X; Zhang J; Chu L
Fundam Clin Pharmacol; 2017 Jun; 31(3):340-346. PubMed ID: 28078759
[TBL] [Abstract][Full Text] [Related]
10. [Effect of bufalin on growth and differentiation of human skin carcinoma cells in vitro].
Akiyama M; Ogura M; Iwai M; Iijima M; Numazawa S; Yoshida T
Hum Cell; 1999 Dec; 12(4):205-9. PubMed ID: 10834107
[TBL] [Abstract][Full Text] [Related]
11. Identification of the hydroxylated derivatives of bufalin: phase I metabolites in rats.
Xin XL; Dong PP; Sun XH; Deng S; Zhang N; Wang C; Huo XK; Li Y; Lan R; Chen L; Fan GJ
J Asian Nat Prod Res; 2016; 18(3):239-47. PubMed ID: 26577491
[TBL] [Abstract][Full Text] [Related]
12. Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions.
Hong SH; Kim GY; Chang YC; Moon SK; Kim WJ; Choi YH
Int J Oncol; 2013 Jan; 42(1):277-86. PubMed ID: 23128598
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
[TBL] [Abstract][Full Text] [Related]
14. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
15. MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
Xiang RF; Wang Y; Zhang N; Xu WB; Cao Y; Tong J; Li JM; Wu YL; Yan H
Cell Death Dis; 2017 May; 8(5):e2776. PubMed ID: 28492559
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of bufalin derivatives with inhibitory activity against prostate cancer cells.
Yuan XF; Tian HY; Li J; Jin L; Jiang ST; Liu KW; Luo C; Middleton DA; Esmann M; Ye WC; Jiang RW
Nat Prod Res; 2014; 28(11):843-7. PubMed ID: 24484199
[TBL] [Abstract][Full Text] [Related]
17. miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells.
Wang Q; Li C; Zhu Z; Teng Y; Che X; Wang Y; Ma Y; Wang Y; Zheng H; Liu Y; Qu X
Anticancer Drugs; 2016 Jan; 27(1):9-16. PubMed ID: 26398931
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on apoptosis of human leukemic cells induced by bufalin].
Xu RC; Chen XY; Chen L; Qian J
Zhongguo Zhong Yao Za Zhi; 2001 Jan; 26(1):59-61. PubMed ID: 12525125
[TBL] [Abstract][Full Text] [Related]
19. Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
Hong SH; Choi YH
Oncol Rep; 2012 Jan; 27(1):114-20. PubMed ID: 21901250
[TBL] [Abstract][Full Text] [Related]
20. Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair.
Zhang X; Huang Q; Wang X; Xu Y; Xu R; Han M; Huang B; Chen A; Qiu C; Sun T; Wang F; Li X; Wang J; Zhao P; Wang X
Biomed Pharmacother; 2017 Oct; 94():627-635. PubMed ID: 28787697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
